ATLAS / Macro Radar / Reporting / CRSP

CRISPR Therapeutics AG (CRSP) reporting calendar

CRISPR Therapeutics AG files periodic reports with the SEC as CRSP on Nasdaq. Atlas tracks 39 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
31 Jul 2026 – 10 Aug 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
4 May 2026
Reports on record
39

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 36 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open CRSP market profile Latest filing on SEC EDGAR ↗ Biological Products, (No Diagnostic Substances) reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 20264 May 202634 days0001193125-26-204188
10-K31 Dec 202512 Feb 202643 days0001193125-26-048957
10-Q30 Sep 202510 Nov 202541 days0001193125-25-273337
10-Q30 Jun 20254 Aug 202535 days0000950170-25-102052
10-Q31 Mar 20256 May 202536 days0000950170-25-064468
10-K31 Dec 202411 Feb 202542 days0000950170-25-017899
10-Q30 Sep 20245 Nov 202436 days0000950170-24-121105
10-Q30 Jun 20245 Aug 202436 days0000950170-24-090746
10-Q31 Mar 20248 May 202438 days0000950170-24-055719
10-K31 Dec 202321 Feb 202452 days0000950170-24-017571
10-Q30 Sep 20236 Nov 202337 days0000950170-23-059476
10-Q30 Jun 20237 Aug 202338 days0000950170-23-039075
10-Q31 Mar 20238 May 202338 days0000950170-23-018811
10-K31 Dec 202221 Feb 202352 days0000950170-23-003441
10-Q30 Sep 20221 Nov 202232 days0000950170-22-020845
10-Q30 Jun 20228 Aug 202239 days0000950170-22-015256
10-Q31 Mar 20229 May 202239 days0000950170-22-008495
10-K31 Dec 202115 Feb 202246 days0000950170-22-001282
10-Q30 Sep 20213 Nov 202134 days0000950170-21-002825
10-Q30 Jun 202129 Jul 202129 days0001564590-21-039178
10-Q31 Mar 202127 Apr 202127 days0001564590-21-020902
10-K31 Dec 202016 Feb 202147 days0001564590-21-006074
10-Q30 Sep 202028 Oct 202028 days0001564590-20-048169
10-Q30 Jun 202027 Jul 202027 days0001564590-20-033602
10-Q31 Mar 202028 Apr 202028 days0001564590-20-019278
10-K31 Dec 201912 Feb 202043 days0001564590-20-004355
10-Q30 Sep 201928 Oct 201928 days0001564590-19-038024
10-Q30 Jun 201929 Jul 201929 days0001564590-19-026600
10-Q31 Mar 201929 Apr 201929 days0001564590-19-013720
10-K31 Dec 201825 Feb 201956 days0001564590-19-004115
10-Q30 Sep 20187 Nov 201838 days0001564590-18-028026
10-Q30 Jun 20187 Aug 201838 days0001564590-18-019945
10-Q31 Mar 20188 May 201838 days0001564590-18-011470
10-K31 Dec 20178 Mar 201867 days0001564590-18-004920
10-Q30 Sep 20178 Nov 201739 days0001564590-17-022720
10-Q30 Jun 201710 Aug 201741 days0001193125-17-254536
10-Q31 Mar 201711 May 201741 days0001193125-17-166631
10-K31 Dec 201610 Mar 201769 days0001564590-17-003977
10-Q30 Sep 201622 Nov 201653 days0001193125-16-774104

Source: SEC EDGAR company submissions for CIK 0001674416. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.